Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 3/20 | 0.44 |
| ▸ | CNR1 | P21554 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 7/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL797349 | 0.82 | CNR1 (0.39) | CNR2CNR1ALDH1A1KDM4EMAPT | |
| SCHEMBL797600 | 0.79 | ABCB11 (0.46) | ALDH1A1KDM4EMAPTHPGDHSD17B10 | |
| SCHEMBL10079132 | 0.79 | CNR2 (0.37) | CNR2CNR1ALDH1A1KDM4EMAPT | |
| SCHEMBL9194914 | 0.76 | LMNA (0.41) | CNR2CNR1ALDH1A1KDM4EHPGD | |
| SCHEMBL796709 | 0.74 | MEN1 (0.39) | CNR2CNR1ALDH1A1KDM4EMAPT | |
| SCHEMBL796328 | 0.74 | KDM4E (0.40) | ALDH1A1KDM4EMAPTHPGDHSD17B10 | |
| SCHEMBL796741 | 0.72 | NPC1 (0.39) | CNR2CNR1ALDH1A1KDM4EMAPT | |
| SCHEMBL10079139 | 0.72 | MEN1 (0.38) | CNR2CNR1ALDH1A1KDM4EMAPT | |
| SCHEMBL13815353 | 0.71 | MEN1 (0.37) | CNR2CNR1ALDH1A1KDM4EMAPT | |
| SCHEMBL6364973 | 0.71 | NR4A2 (0.46) | ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1262469-B1 | POLYACENE DERIVATIVES AND PRODUCTION THEREOF | JAPAN SCIENCE & TECH AGENCY (JP) | 2012-01-11 | — | — | EP | disclosed |
| US-7901594-B2 | Electroconductivity | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20050240061-A1 | Functional thin film | JAPAN SCIENCE AND TECHNOLOGY AGENCY | 2005-10-27 | — | — | US | disclosed |
| EP-1493796-A1 | FUNCTIONAL THIN FILM | Japan Science and Technology Agency (JP) | 2005-01-05 | — | — | EP | disclosed |
| US-20030116755-A1 | Polyacene derivatives and production thereof | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2003-06-26 | — | — | US | disclosed |
| EP-1262469-A1 | POLYACENE DERIVATIVES AND PRODUCTION THEREOF | Japan Science and Technology Corporation (JP) | 2002-12-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050240061-A1 | Functional thin film | H1-10, H1-0, H1-2 | CNR2 3581/4885CNR1 3092/4885USP2 3034/4885 |
| US-20030116755-A1 | Polyacene derivatives and production thereof | CBR1, HVCN1, H1-0 | CNR2 1020/4885CNR1 492/4885USP2 4245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.